Medical Diagnostics

Medical diagnostic reagents and equipment are used to perform diagnostic tests in hospitals, commercial laboratories, physicians’ offices and blood banks. Reagents are an essential component of any healthcare regime, indispensable in preventing sickness, detecting and diagnosing diseases, ascertaining the side effects of drug therapy, monitoring treatment, improving patient quality of life and decreasing total healthcare costs. Repeated cuts to reimbursement prices have reduced pricing levels in Japan below those of comparable overseas markets. The current regulatory structure and reimbursement regime constitute an obstacle to introducing new products the Japanese market and the committee aims to overcome these problems.

View Issues and Recommendations
– (English | Japanese) PDF - Updated


Chairman:
Dr. Isao Ikeda
Representative Director & Chairman of the Board and President, Abbott Japan Co., Ltd.
Roppongi First Bldg. 4F.
1-9-9 Roppongi
Minato-ku, Tokyo 106-8535
Tel: +81-3-3589-9600 | Fax: +81-3-3589-9404

Members:
Abbott Japan Co., Ltd
Ortho-Clinical Diagnostic K.K.
Roche Diagnostics K.K.
SML KK
Sysmex bioMerieux Co., Ltd.

Upcoming Committee Meeting Schedule:
Please contact the EBC ( This e-mail address is being protected from spambots. You need JavaScript enabled to view it ) to confirm the meeting location prior to attending

TBA

 

- Updated on: 2011-03-03
 

Premier Members

Banner
Banner

EBC Sponsors

Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner
Banner

2011 EBC White Paper: Blue-Star Sponsors

Bayer Holding Ltd.
Freshfields Bruckhaus Deringer
Gambro
IKEA
ING
Johnson & Johnson
Philips Electronics Japan, Ltd.